ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.
A phase I trial in 118 patients showed safety in humans.
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".